Dr. Reddys Laboratories Ltd. and Russian Direct Investment Fund (RDIF) announced on Tuesday that they have commenced adaptive Phase 2 and 3 clinical trials for Sputnik V vaccine in India for COVID-19 after receiving the necessary clearance from the Central Drugs Laboratory, Kasauli.